BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16735372)

  • 1. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.
    Hamashima C; Sobue T; Muramatsu Y; Saito H; Moriyama N; Kakizoe T
    Jpn J Clin Oncol; 2006 May; 36(5):301-8. PubMed ID: 16735372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening--comparison of computed tomography and X-ray.
    Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
    Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history of cancer in a female cohort population in Japan.
    Murata M; Takayama K; Nagashima Y
    Cancer Detect Prev; 1991; 15(1):69-75. PubMed ID: 2044077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer occurrence and screening in family practice. A 20-year experience.
    Kiernan GN; Frame PS
    J Fam Pract; 1996 Jul; 43(1):49-55. PubMed ID: 8691180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of screening for cancer in Japanese in the prime of life--an analysis of nationwide MHTS and human dry dock statistics--Preventive Medicine Committee of the Japan Hospital Association.
    Sasamori N; Hinohara S; Tamura M; Kiyose H; Amakawa T; Tsuchiya A; Nara M
    Jpn Hosp; 1999 Jul; (18):71-8. PubMed ID: 11184926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
    Roobol MJ; Grenabo A; Schröder FH; Hugosson J
    J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.
    Kaida H; Ishibashi M; Fujii T; Kurata S; Ogo E; Tanaka M; Hayabuchi N
    Ann Nucl Med; 2008 Feb; 22(2):95-101. PubMed ID: 18311533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead time of prostate cancer detected in population based screening for prostate cancer in Japan.
    Ito K; Yamamoto T; Miyakubo M; Takechi H; Ohi M; Shibata Y; Suzuki K
    J Urol; 2007 Oct; 178(4 Pt 1):1258-63; discussion 1263-4. PubMed ID: 17698107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in cancer mortality, incidence and survival in Japan.
    Tominaga S
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1113-20. PubMed ID: 1514821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer screening].
    Akaza H; Tsuruo T; Saijo N; Sone S; Isonishi S; Ohashi Y; Sobue T; Yamanaka H; Fukuda M; Maruyama M; Eguchi K; Ito K; Smith M; Milsted B
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):125-34. PubMed ID: 15675598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI screening in a clinic population with a family history of breast cancer.
    Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
    Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer incidence in middle-aged men estimated by low-dose computed tomography screening.
    Nojo T; Imanaka Y; Ishizaki T; Sekimoto M; Yoshino M; Kurosawa T; Takao H; Ohtomo K
    Lung Cancer; 2009 Jul; 65(1):56-61. PubMed ID: 19019487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer in Lebanon: analysis of 10,220 cases from the American University of Beirut Medical Center.
    el Saghir NS; Adib S; Mufarrij A; Kahwaji S; Taher A; Issa P; Shamseddine AI
    J Med Liban; 1998; 46(1):4-11. PubMed ID: 9795515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screenings, diagnostic technology evolution, and cancer control.
    Stracci F
    Methods Mol Biol; 2009; 471():107-36. PubMed ID: 19109777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer control activities in the Republic of Korea.
    Yoo KY
    Jpn J Clin Oncol; 2008 May; 38(5):327-33. PubMed ID: 18407932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry.
    Suzuki A; Kuriyama S; Kawai M; Amari M; Takeda M; Ishida T; Ohnuki K; Nishino Y; Tsuji I; Shibuya D; Ohuchi N
    Cancer Sci; 2008 Nov; 99(11):2264-7. PubMed ID: 18795941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
    Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.